Literature DB >> 19789728

Intratubular Renin-Angiotensin System in Hypertension.

Yuki Suzaki1, Minolfa C Prieto-Carrasquero, Hiroyuki Kobori.   

Abstract

It is well recognized that the renin-angiotensin system plays an important role in the regulation of arterial pressure and sodium homeostasis. Recent years, many studies have shown that local tissue angiotensin II levels are differentially regulated and cannot be explained on the basis of circulating concentrations. All of the components needed for angiotensin II generation are present within the various compartments in the kidney including the renal interstitium and the tubular network. The cascade of the renin-angiotensin system demonstrates three major possible sites for the pharmacological interruption of the renin-angiotensin system: the interaction of renin with its substrate, angiotensinogen, the angiotensin converting enzyme, and angiotensin II type 1 receptors. This brief article will focus on the role of the intratubular renin-angiotensin system in the pathophysiology of hypertension and the responses to the renin-angiotensin system blockade by renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockers.

Entities:  

Year:  2006        PMID: 19789728      PMCID: PMC2752977          DOI: 10.2174/157340206776877325

Source DB:  PubMed          Journal:  Curr Hypertens Rev        ISSN: 1573-4021


  99 in total

Review 1.  Contribution of angiotensin-(1-7) to cardiovascular physiology and pathology.

Authors:  Carlos M Ferrario
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

2.  Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide.

Authors:  R Munoz-Garcia; R Maeso; E Rodrigo; J Navarro; L M Ruilope; M C Casal; V Cachofeiro; V Lahera
Journal:  J Hypertens       Date:  1995-12       Impact factor: 4.844

3.  The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.

Authors:  H H Parving; H Lehnert; J Bröchner-Mortensen; R Gomis; S Andersen; P Arner
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

4.  ANG II chronically supports renal and lumbar sympathetic activity in sodium-deprived, conscious rats.

Authors:  L Xu; V L Brooks
Journal:  Am J Physiol       Date:  1996-12

5.  Angiotensin I-converting enzyme activity in tubular fluid along the rat nephron.

Authors:  D E Casarini; M A Boim; R C Stella; M H Krieger-Azzolini; J E Krieger; N Schor
Journal:  Am J Physiol       Date:  1997-03

Review 6.  Renin inhibition: what are the therapeutic opportunities?

Authors:  Naomi D L Fisher; Norman K Hollenberg
Journal:  J Am Soc Nephrol       Date:  2005-02-09       Impact factor: 10.121

7.  Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect.

Authors:  Giancarlo Viberti; Nigel M Wheeldon
Journal:  Circulation       Date:  2002-08-06       Impact factor: 29.690

8.  In situ hybridization and immunohistochemistry of renal angiotensinogen in neonatal and adult rat kidneys.

Authors:  I A Darby; C Sernia
Journal:  Cell Tissue Res       Date:  1995-08       Impact factor: 5.249

9.  Changes in single nephron renin release are mediated by tubular fluid flow rate.

Authors:  P P Leyssac
Journal:  Kidney Int       Date:  1986-09       Impact factor: 10.612

10.  Kinin influences on renal regional blood flow responses to angiotensin-converting enzyme inhibition in dogs.

Authors:  S A Omoro; D S Majid; S S El-Dahr; L G Navar
Journal:  Am J Physiol       Date:  1999-02
View more
  3 in total

Review 1.  Physiology and Pathophysiology of the Intrarenal Renin-Angiotensin System: An Update.

Authors:  Tianxin Yang; Chuanming Xu
Journal:  J Am Soc Nephrol       Date:  2017-03-02       Impact factor: 10.121

2.  Crucial role of Rho-nuclear factor-kappaB axis in angiotensin II-induced renal injury.

Authors:  Yuri Ozawa; Hiroyuki Kobori
Journal:  Am J Physiol Renal Physiol       Date:  2007-04-04

3.  The succinate receptor as a novel therapeutic target for oxidative and metabolic stress-related conditions.

Authors:  Ana Carolina Ariza; Peter Meinardus T Deen; Joris Hubertus Robben
Journal:  Front Endocrinol (Lausanne)       Date:  2012-02-16       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.